gvtcx

Contract for the supply of live attenuated intranasal influenza vaccine

Department of Health and Social Care (DHSC) Published 23 Apr 2021 Contracts Finder

key details

Statuscomplete
Category (CPV) 33651660
Deadline19 Mar 2021
Contract start1 Aug 2021
Contract end31 Jul 2022
Procedurelimited
SME suitableNo
OCIDocds-b5fd17-ab2d22d6-558e-4966-8fcd-5612df9befa6

Award

SupplierValueDateStatus
AstraZeneca £1 20 Mar 2021 active

description

The provision of a live attenuated intranasal influenza vaccine, to be used to support the annual seasonal influenza vaccination programme, which includes children. The volume requirement is 3,364,470 doses of vaccine.

Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
23 Apr 2021 Award (award) · feb4b7cc-f02f-47be-b23e-d4a8c8175b8a-431040

more from Department of Health and Social Care (DHSC)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.